Qianjin Lu, Hai Long, Steven Chow, Syarief Hidayat, Retno Danarti, Yulianto Listiawan, Danqi Deng, Qing Guo, Hong Fang, Juan Tao, Ming Zhao, Leihong Xiang, Nan Che, Fen Li, Hongjun Zhao, Chak Sing Lau, Fong Cheng Ip, King Man Ho, Arnelfa C Paliza, Chan Vicheth, Kiran Godse, Soyun Cho, Chew Swee Seow, Yoshiki Miyachi, Tran Hau Khang, Rataporn Ungpakorn, Hassan Galadari, Rashmikant Shah, Kehu Yang, Youwen Zhou, Carlo Selmi, Amr H Sawalha, Xuan Zhang, Yaolong Chen, Chrang-Shi Lin
Cutaneous lupus erythematosus (CLE) is an inflammatory, autoimmune disease encompassing a broad spectrum of subtypes including acute, subacute, chronic and intermittent CLE. Among these, chronic CLE can be further classified into several subclasses of lupus erythematosus (LE) such as discoid LE, verrucous LE, LE profundus, chilblain LE and Blaschko linear LE. To provide all dermatologists and rheumatologists with a practical guideline for the diagnosis, treatment and long-term management of CLE, this evidence- and consensus-based guideline was developed following the checklist established by the international Reporting Items for Practice Guidelines in Healthcare (RIGHT) Working Group and was registered at the International Practice Guideline Registry Platform...
September 2021: Journal of Autoimmunity